ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
9 |
17/08/24 |
17/08/24 |
ASX - By Stock
|
471
|
219K
|
9
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
18 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
471
|
219K
|
18
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
6 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
471
|
219K
|
6
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Visual Improvement in Multiple RP11 Patients
|
|
actionnaire
|
27 |
9.2K |
6 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
27
|
9.2K
|
6
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
7 |
11/08/24 |
11/08/24 |
ASX - By Stock
|
471
|
219K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
25 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
471
|
219K
|
25
|
|
ASX - By Stock
|
PYC |
Re:
Ann: RP11 Clinical Trial Update - Amended
|
|
actionnaire
|
23 |
7.3K |
3 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
23
|
7.3K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: RP11 Clinical Trial Update
|
|
actionnaire
|
30 |
11K |
10 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
30
|
11K
|
10
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
9 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
471
|
219K
|
9
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
16 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
471
|
219K
|
16
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
5 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
471
|
219K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
1 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
471
|
219K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
0 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
471
|
219K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
4 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
471
|
219K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
8 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
471
|
219K
|
8
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of RP11 Multiple Dose Trial
|
|
actionnaire
|
55 |
21K |
0 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
55
|
21K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of RP11 Multiple Dose Trial
|
|
actionnaire
|
55 |
21K |
0 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
55
|
21K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of RP11 Multiple Dose Trial
|
|
actionnaire
|
55 |
21K |
0 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
55
|
21K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
actionnaire
|
15K |
7.2M |
26 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
15K
|
7.2M
|
26
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of RP11 Multiple Dose Trial
|
|
actionnaire
|
55 |
21K |
5 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
55
|
21K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of RP11 Multiple Dose Trial
|
|
actionnaire
|
55 |
21K |
1 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
55
|
21K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of RP11 Multiple Dose Trial
|
|
actionnaire
|
55 |
21K |
0 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
55
|
21K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
Question for holders about exclusivity.
|
|
actionnaire
|
13 |
5.3K |
18 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
13
|
5.3K
|
18
|
|
ASX - By Stock
|
PYC |
Re:
Ann: RP11 Drug Candidate Safe and Well Tolerated
|
|
actionnaire
|
5 |
3.0K |
12 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
5
|
3.0K
|
12
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
1 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
471
|
219K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
2 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
471
|
219K
|
2
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
actionnaire
|
172 |
80K |
6 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
172
|
80K
|
6
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
actionnaire
|
172 |
80K |
5 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
172
|
80K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
4 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
471
|
219K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
13 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
471
|
219K
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
actionnaire
|
15K |
7.2M |
0 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
15K
|
7.2M
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
actionnaire
|
15K |
7.2M |
6 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
15K
|
7.2M
|
6
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
3 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
471
|
219K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
actionnaire
|
15K |
7.2M |
81 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
15K
|
7.2M
|
81
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PMS Drug Candidate Effective In Human Brain Cells
|
|
actionnaire
|
30 |
10K |
14 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
30
|
10K
|
14
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
1 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
471
|
219K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
actionnaire
|
471 |
219K |
1 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
471
|
219K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
News clipping
|
|
actionnaire
|
10 |
5.4K |
13 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
10
|
5.4K
|
13
|
|
ASX - By Stock
|
PYC |
Re:
News clipping
|
|
actionnaire
|
10 |
5.4K |
2 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
10
|
5.4K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
actionnaire
|
15K |
7.2M |
23 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
15K
|
7.2M
|
23
|
|
ASX - By Stock
|
PYC |
Re:
FDA orphan designation
|
|
actionnaire
|
14 |
7.1K |
19 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
14
|
7.1K
|
19
|
|
ASX - By Stock
|
PYC |
Re:
FDA orphan designation
|
|
actionnaire
|
14 |
7.1K |
2 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
14
|
7.1K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Small Shareholdings Sale Facility
|
|
actionnaire
|
2 |
1.1K |
3 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
2
|
1.1K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Change of Director's Interest Notice
|
|
actionnaire
|
2 |
1.2K |
11 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
2
|
1.2K
|
11
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Successful GLP Tox Studies in Second Blinding Eye Disease
|
|
actionnaire
|
21 |
9.6K |
1 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
21
|
9.6K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Successful GLP Tox Studies in Second Blinding Eye Disease
|
|
actionnaire
|
21 |
9.6K |
1 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
21
|
9.6K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
actionnaire
|
35 |
23K |
7 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
35
|
23K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q2 2024 Investor Webinar Presentation
|
|
actionnaire
|
23 |
7.4K |
8 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
23
|
7.4K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference
|
|
actionnaire
|
221 |
107K |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
221
|
107K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference
|
|
actionnaire
|
221 |
107K |
3 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
221
|
107K
|
3
|
|